List of contributions Health Economics Conference 2025

WEDNESDAY, JUNE 18, 2025

KEYNOTE LECTURE (Auditorium 3)

Chair: Pierre Dubois (TSE, CEPR)

Liran Einav (Stanford University) 

“Health and Longevity in the US: Evidence and Implications" (with Amy Finkelstein) -> please email Liran <leinav@stanford.edu> for the slides

PARALLEL SESSION 1A - Healthcare Funding and Pricing (Auditorium 3)

Chair: Léa Bignon (TSE)

• David Ridley (Duke University), Chenxi Xu (Duke University, CEPR) and Peng Sun (Duke University) “Optimal Push and Pull Funding for Global Health”

• Luca Maini (Harvard University), Emma B. Dean (The Dartmouth Institute) and Josh Feng (University of Utah) “Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization”

• Luis Sa (Nova School of Business & Economics), Pedro Pita Barros (Nova School of Business & Economics) and Giovanni Righetti (Nova School of Business & Economics) “Pricing Mechanisms for Multi-Indication Drugs”

PARALLEL SESSION 1B - Cost-Sharing, and Subsidies in Healthcare (Auditorium 4)

Chair: Santiago Ortiz (TSE)

• Chiara Gardenghi (New York University) “Bundled Loyalty Discounts in Healthcare: Evidence from Physician-Administered Vaccines”

• Martin Salm (Tilburg University) and Tobias J. Klein (Tilburg University, CEPR) “Is physician cost-sharing an alternative to patient cost-sharing?”

• Gosia Majewska (ESSEC Business School, Paris) and Krzysztof Zaremba (Instituto Tecnologico Autonomo de Mexico) “Universal Subsidies in Pharmaceutical Markets: Lessons from Poland’s Drugs 75+ Policy”

PLENARY SESSION 1 - Innovation, Entry, and Price Regulation in Healthcare (Auditorium 3)

Chair: Angie Acquatella (TSE)

• Rebekah Dix (MIT) and Todd Lensman (MIT) “Combining Complements: Theory and Evidence from Cancer Treatment Innovation”

• Rena Conti (Boston University) and Rubaiyat Alam (Kansas State University) “Entry Delays and Fighting Brands: Evidence from Generics and Authorized Generics”

• Yunan Ji (Georgetown University) and Parker Rogers (Indiana University) “The Long-Run Impacts of Regulated Price Cuts: Evidence from Medicare”

PARALLEL SESSION 2A - Management and Costs in Healthcare (Auditorium 3)

Chair: Charu Gupta (UCLA)

• Tuomas Markkula (Aalto University) “Cutting the Queue to the Dentist: Waiting Time, Public-Private Interaction and Consumer Surplus”

• Carol Propper (Imperial College) “The Role of Top Managers in the Public Sector: Evidence from the English NHS”

• Robert Gary-Bobo (Univ. Paris 1, CREST, CEPR) and Solen Croiset (Univ. Paris 1) “A Finite-Mixture Approach to Cost-Function Estimation: Economies of Density in Home-Care Services”

PARALLEL SESSION 2B - Physician Behavior (Auditorium 4)

Chair: Catarina Goulão (TSE)

• Franziska Valder (University of Copenhagen) “Gender disparities in heart disease: individual and provider behavior”

• Juan Pablo Atal (University of Pennsylvania), Tomas Larroucau (University of Arizona), Pablo Munoz (Universidad de Chile) and Cristobal Otero (Columbia Business School) “Physicians' Occupational Licensing and the Quantity-Quality Trade-off”

• Lionel Wilner (CREST, Paris), Philippe Choné (CREST, Paris, CEPR) and Francis Kramarz (Collège de France, CEPR) “Physician labor supply, financial incentives, and healthcare accessibility”

POLICY ROUNDTABLE - Challenges for European Pharmaceutical Innovation Policy (Auditorium 3)

Chair : Jean Tirole (TSE, CEPR)

• Pedro Pita Barros (Nova School of Business and Economics)

• Tina Taube (EFPIA)

• Jean Tirole (TSE, CEPR)

• Adrian Towse (OHE UK) 

THURSDAY, JUNE 19, 2025

POLICY ROUNDTABLE - Policies against Antimicrobial Resistance (Auditorium 3)

Chair : Pierre Dubois (TSE, CEPR)

• Pierre Dubois (TSE, CEPR)

• Aleksandra Opalska (Directorate-General for Health and Food Safety, European Commission)

• John Rex (AMR.Solutions - F2G Ltd)

• Henry Skinner (CEO, AMR Action Fund) 

PARALLEL SESSION 3A - Plan Design and Hospital Reforms (Auditorium 3)

Chair: Valentina Reig (TSE)

• Natalia Serna (Stanford University), Giancarlo Buitrago (Universidad Nacional de Colombia), Paul Rodríguez-Lesmes (Universidad del Rosario) and Marcos Vera-Hernández (University College London, CEPR) “Enrollee Reassignment Rules After Health Plan Terminations”

• Benjamin Vatter (MIT), José Ignacio Cuesta (Stanford University) and Carlos Noton (PUC-Chile) “Vertical Integration and Plan Design in Healthcare Markets”

• Angie Acquatella (TSE) and Victoria Marone (University of Texas at Austin) “The Risk Protection Value of Moral Hazard”

PARALLEL SESSION 3B - Price Controls and Regulation in Pharma (Auditorium 4)

Chair: Giulia Tani (TSE)

• Harsh Gupta (Stanford University) and Shengmao Cao (Northwestern University) “Price Controls with Imperfect Competition and Choice Frictions: Evidence from Indian Pharmaceuticals”

• Jiekai Zhang (Hanken School of Economics, Helsinki), Mikko Vanhala (University of Helsinki) and Markku Siikanen (VATT Research Institute) “Optimal Retail Pharmaceutical Pricing Policy”

• Debi Prasad Mohapatra (University of Massachusetts, Amherst) and Pierre Dubois (TSE, CEPR) “Regulating Trade Margins and Consumer Welfare: Evidence from Cardiac Products in India”

KEYNOTE LECTURE (Auditorium 3)

Chair: Jean Tirole (TSE, CEPR)

Nikhil Agarwal (MIT)
“Human-AI Collaboration in Healthcare”

PARALLEL SESSION 4A - Physicians’ Incentives and Decisions (Auditorium 3)

Chair: Philippe De Donder (TSE)

• Isabel Stockton (Institute for Fiscal Studies, London) and Elaine Kelly (Institute for Fiscal Studies, London) “A senior doctor like me: Gender match and occupational choice”

• Andre Veiga (Imperial College), Filippo Paternollo (Columbia University) and Pietro Tebaldi (Columbia University) “Designing Incentives for Multitasking Agents: Evidence from Payments to Physicians in England”

• Philippe De Donder (TSE), David Bardey (Universidad de Los Andes, Bogota) and Marie-Louise Leroux (ESG-UQAM, Montréal) “Incentivizing Physicians’ Diagnostic Effort and Test with Moral Hazard and Adverse Selection”

PARALLEL SESSION 4B - Generics, Biosimilars, Vaccine Skepticism (Auditorium 4)

Chair: Xin Zhang (TSE)

• Catherine Ishitani (University of Pennsylvania) “In Defense of the Middleman: Quality Failures in the Generic Pharmaceutical Market”

• Otto Toivanen (Aalto University), Antto Jokelainen (Aalto University), Jaakko Markkanen (ETLA), Samuli Leppälä (FCCA), Markku Siikanen (VATT) and Matti Sipiläinen (FCCA) “Free Entry and Social Inefficiency in Regulated Pharmacy Markets”

• Manuel Hermosilla (University of Illinois at Chicago), Joseph Levy (Johns Hopkins University) and Kelly E. Anderson (University of Colorado) “Biosimilar Turf Wars”

PLENARY SESSION 2 - Bargaining and Competition (Auditorium 3)

Chair: Thierry Magnac (TSE)

• Amanda Starc (Northwestern University), Aslihan Asil (Yale Law School), Paulo Ramos (University of Chicago) and Thomas G. Wollmann (University of Chicago) “Painful Bargaining Evidence from Anesthesia Rollups”

• Riley League (University of Illinois, Urbana Champaign), Renuka Diwan (Boston University), Paul Eliason (University of Utah), Jetson Leder-Luis (Boston University), Ryan C. McDevitt (Duke University) and James W. Roberts (Duke University) “Competition and Fraud in Health Care“

• Ashley Swanson (University of Wisconsin), Panle Jia Barwick (University of Wisconsin, CEPR) and Tianli Xia (University of Rochester) “A Double Dose of Reform: Insurance and Centralized Negotiation in Drug Markets”